RxDoctor Payments Data

Anthony Sierra, MD

Obstetrics & Gynecology · Sioux Falls, SDNPI 1942283163

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Daiichi Sankyo Inc. at 25.5% of the total. Reporting peaked in 2019 at $165 and has fallen 77.8% since, to $37 in 2025.

$388in general payments, 2019–2025

Across 25 payments — averaging $15.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$99
  • Coloplast$62
  • Mallinckrodt Enterprises LLC$43
  • Hologic Sales And Service, LLC$31
  • Pelvital USA, Inc.$23
  • AbbVie$22
  • plus $110 from 7 others

What the payments were for

  • Food & beverage$388100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$388 in reported general payments places this provider in the 60th percentile of 96 obstetrics & gynecology providers in South Dakota.

See all obstetrics & gynecology providers in South Dakota

Medicare billing

Part B allowed, 2024
$19,878
Medicare patients
53
Services billed
108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol58$923
Medroxyprogesterone Acetate15$147

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →